|
| Press Releases |
|
 |
|
| Thursday, December 1, 2016 |
|
|
Luye Pharma Announces the Completion of Acquisition of Acino's Transdermal Drug Delivery Systems Business |
| Luye Pharma Group Ltd. (2186.HK) is pleased to announce the completion of its acquisition of the transdermal drug delivery systems (TDS) business from Swiss company, Acino. The acquired business is a global leader in niche transdermal markets and will greatly enhance Luye's developmental efforts in R&D, more info >> |
|
| Tuesday, July 26, 2016 |
|
|
綠葉製藥國際化邁出里程碑意義的一步 宣布簽約收購瑞士Acino公司之透皮釋藥業務 |
| 2016年7月25日，綠葉製藥集團有限公司(2186.HK)欣然宣布，與瑞士Acino公司簽約，以2.45億歐元購買旗下透皮釋藥業務，即Acino AG和Acino Supply AG（統稱“標的公司”）全部發行之股本。 more info >> |
|
|
绿叶制药国际化迈出里程碑意义的一步 宣布签约收购瑞士Acino公司之透皮释药业务 |
| 2016年7月25日，绿叶制药集团有限公司(2186.HK)欣然宣布，与瑞士Acino公司签约，以2.45亿欧元购买旗下透皮释药业务，即Acino AG和Acino Supply AG（统称“标的公司”）全部发行之股本。 more info >> |
|
|
Luye Pharma Takes a Milestone Step Forward; Proposed Acquisition of Acino's TDS Business |
Luye Pharma Group Ltd. (2186.HK) (the "Company", and together with its subsidiaries, "Luye Pharma" or the "Group") announces its agreement to acquire the TDS business from Acino, through the purchase of the entire issued share capital of Acino AG and Acino Supply AG (the "Target Group") for EUR245,000,000 (the "Acquisition").
more info >> |
|
| Friday, May 6, 2016 |
|
|
Luye Medical welcomes Australia's Healthe Care to its Group |
| Healthe Care, Australia's third largest private healthcare group, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund completed on April 18. more info >> |
|
| Sunday, April 24, 2016 |
|
|
Singapore-based Luye Medical Group Completes Acquisition of Healthe Care, Australia's Third Largest Private Healthcare Group |
| On April 18, 2016, Australia's third largest private healthcare group, Healthe Care, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund was completed. more info >> |
|
| Friday, October 9, 2015 |
|
|
China's First Innovative Drug Led by Luye Pharma Approved NDA in the U.S. |
| The leading innovative pharmaceutical company with strong R&D capability and global vision in China market-Luye Pharma Group Ltd. (the "Company", together with its subsidiaries, "Luye", stock code: 2186.HK), announced that the United States Food and Drug Administration (the "FDA") has confirmed that no additional clinical trials are needed for the New Drug Application ("NDA") submission for Risperidone Extended-release Microspheres for Injection ("LY03004") in the U.S. more info >> |
|
|
由綠葉製藥研發的我國首個創新藥獲批在美提交新藥申請 |
| 以研發為驅動，以國際化為目標的中國領先創新製藥企業--綠葉製藥集團(簡稱「公司」，連同其附屬公司，統稱「綠葉」，股份代號：2186.HK)，近日宣佈，美國食品藥品監督管理局（FDA）確認公司研發的利培酮微球注射劑（LY03004）不需再進行任何臨床試驗，可在美提交新藥申請（NDA）。 more info >> |
|
| Tuesday, June 2, 2015 |
|
|
綠葉製藥宣佈終止收購北京嘉林藥業股權之協議 |
以研發為驅動，以國際化為目標的中國領先創新製藥企業--綠葉製藥集團(股份代號：2186.HK)宣佈，終止收購北京嘉林藥業股份有限公司之股權協議。公司股票在短暫停牌後於今日恢復交易。
more info >> |
|
| Thursday, May 14, 2015 |
|
|
綠葉製藥被納入MSCI中國指數 |
| 以研發為驅動，以國際化為目標的中國領先創新製藥企業--绿叶制药集团(股份代號：2186.HK)宣佈绿叶獲納入摩根士丹利資本國際(「MSCI」)環球標準指數系列中的中國指數成分股，將於今年5月29日收市後生效 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Entertainment Expo Hong Kong shines on the centre stage, Eight signature events unite global film and entertainment forces
Mar 9, 2026 19:04 HKT/SGT
|
|
|
「新增長機遇-新資產敘事」廣發証券2026年春季資本論壇成功舉辦
Mar 9, 2026 15:27 HKT/SGT
|
|
|
"新增长机遇-新资产叙事"广发证券2026年春季资本论坛成功举办
Mar 9, 2026 15:27 HKT/SGT
|
|
|
今天，五一視界納入港股通正式生效！
Mar 9, 2026 15:23 HKT/SGT
|
|
|
今天，五一视界纳入港股通正式生效！
Mar 9, 2026 15:23 HKT/SGT
|
|
|
Raya Blooms in the Heart of Nature at Spritzer EcoPark
Mar 9, 2026 14:23 HKT/SGT
|
|
|
Huatai Securities Convenes 2026 Spring Investment Summit in Shanghai
Mar 9, 2026 14:15 HKT/SGT
|
|
|
Fujitsu and DT-Axis collaborate to advance digital health
Mar 9, 2026 13:32 JST
|
|
|
中國工業機器人龍頭埃斯頓於香港聯交所主板正式掛牌
Mar 9, 2026 11:44 HKT/SGT
|
|
|
LEXUS、ミラノデザインウィーク2026出展を発表
Mar 9, 2026 11:00: JST
|
|
|
富士通とＤＴアクシス、デジタルヘルスの発展を目指し、プログラム医療機器（SaMD）開発支援における協業を開始
Mar 9, 2026 10:50: JST
|
|
|
Fosun International: One-Off Non-Cash Impairment Provisions for Certain Non-Core Businesses, Core Industries Maintain Sound Development Momentum
Mar 9, 2026 10:41 HKT/SGT
|
|
|
復星國際：對部分非核心業務一次性計提非現金減值 核心產業發展向好
Mar 9, 2026 10:34 HKT/SGT
|
|
|
AI Labs Introduces AI-Assisted Crypto Trading Platform Focused on Data Analysis and Automated Execution
Mar 9, 2026 09:40: JST
|
|
|
AI Labs Introduces AI-Assisted Crypto Trading Platform Focused on Data Analysis and Automated Execution
Mar 9, 2026 08:40 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
